Startups 

Onicor is a MedTech startup focused on transforming the treatment of onychomycosis (fungal nail infections), a common yet often undertreated condition affecting millions worldwide. Despite its high prevalence, current treatment options remain limited by long treatment durations, suboptimal cure rates, systemic side effects, or poor patient adherence. Onicor is building a new generation of targeted, patient-friendly solutions designed to overcome these limitations and meaningfully improve clinical outcomes. 

Our approach centers on combining scientific rigor with practical usability. Onicor aims to create treatments that are more effective, safer, and easier for patients to complete. We believe that innovation in this space must address not only fungal eradication but also convenience, comfort, and real-world compliance. 

Onicor collaborates with leading academic and innovation partners to strengthen its scientific and technological foundation in onychomycosis treatment. Through its partnership with Radboud University Medical Center, Onicor integrates clinical and translational research expertise to ensure its solutions are grounded in robust medical science. In collaboration with Antleron, the company leverages advanced bioprocessing and precision development capabilities to support scalable and optimized therapeutic delivery. Onicor also works with UCS and Etnogal, contributing complementary expertise in research validation, technical development, and innovation support. Together, these partnerships position Onicor within a multidisciplinary European ecosystem that accelerates development, strengthens clinical validation, and supports the efficient translation of innovation into real-world therapeutic impact. 

Beyond clinical impact, our mission is to restore confidence and quality of life for patients affected by nail fungal infections. Onicor envisions a future where onychomycosis can be treated reliably, safely, and without the frustration associated with today’s therapies. By addressing a large, underserved market with innovative technology and patient-centered design, Onicor is positioned to redefine the standard of care in nail antifungal treatment.